Scan to download
BTC $60,975.15 -2.86%
ETH $1,569.35 -6.66%
BNB $575.99 -3.28%
XRP $1.09 -4.00%
SOL $62.63 -5.73%
TRX $0.3194 -2.04%
DOGE $0.0812 -4.39%
ADA $0.1566 -3.89%
BCH $222.74 -2.48%
LINK $7.34 -4.09%
HYPE $59.22 -3.89%
AAVE $61.42 -10.22%
SUI $0.7033 -1.44%
XLM $0.1998 +3.49%
ZEC $365.57 +4.60%
BTC $60,975.15 -2.86%
ETH $1,569.35 -6.66%
BNB $575.99 -3.28%
XRP $1.09 -4.00%
SOL $62.63 -5.73%
TRX $0.3194 -2.04%
DOGE $0.0812 -4.39%
ADA $0.1566 -3.89%
BCH $222.74 -2.48%
LINK $7.34 -4.09%
HYPE $59.22 -3.89%
AAVE $61.42 -10.22%
SUI $0.7033 -1.44%
XLM $0.1998 +3.49%
ZEC $365.57 +4.60%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.